Purpose: The effect of omeprazole on the oral bioavailability and urinary exposure of the Depomed formulation of extended-release(ER) ciprofloxacin was studied. Methods: A two-way crossover study ...
Methods: All patients received 1 week of triple therapy. Patients in group A (low-dose regimen) received omeprazole 40 mg/day + amoxicillin 1500 mg/day + clarithromycin 800 mg/day; patients in ...
Dear Dr. Roach: Several months ago, I developed a case of a bigeminy heartbeat. My cardiologist prescribed metoprolol. At ...
Ramadan na holy month wey Muslims all ova di world dey observe by fasting from sunrise to sunset. But if you get diabetes, ...
Several months ago, I developed a case of a bigeminy heartbeat. My cardiologist prescribed metoprolol. At about the same time, I had reduced my intake of magnesium from about 50% of the daily value ...
Several months ago, I developed a case of a bigeminy heartbeat. My cardiologist prescribed metoprolol. At about the same time, I had reduced my intake of magnesium from about 50% of the daily value ...
Reimer and colleagues 1 report results from a randomized, double-blind, placebo-controlled study of healthy individuals who received 40 mg daily doses ... of treatment with omeprazole in healthy ...
I walk 40 minutes to 1 hour over a very hilly course ... I have Barrett’s esophagus that is monitored every three years and take 20 mg of omeprazole for it. I also take 2,000 IU of vitamin ...
The photographs don’t do justice to the MG Windsor. Only when you view it in the metal do you get a sense of just how spacious the EV is. It follows a practical, no-fuss approach to design both ...
MG Motor India has launched the new Comet EV Blackstorm edition priced at Rs 7.80 lakh, featuring an all-black design with red accents. The Blackstorm edition retains the powertrain of the ...
Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G) Fabhalta is the only oral alternative complement pathway ...
Patients treated with ESK-001 for moderate to severe plaque psoriasis experienced positive clinical responses through a year, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback